High levels of GREM1 are also associated with poorer patient prognosis in, for example, colorectal and breast cancer (Davis et al. 2015; Dutton et al. 2019b; Neckmann et al. 2019), suggesting an oncogenic function for GREM1 in cancer. The gene discussed is GREM1; the disease is cancer.